about
CIP2A expression is increased in prostate cancerDepletion of IK causes mitotic arrest through aberrant regulation of mitotic kinases and phosphatasesIκB kinases increase Myc protein stability and enhance progression of breast cancer cellsDeconstruction of the SS18-SSX fusion oncoprotein complex: insights into disease etiology and therapeuticsPME-1 protects extracellular signal-regulated kinase pathway activity from protein phosphatase 2A-mediated inactivation in human malignant gliomaOver expression of PPP2R2C inhibits human glioma cells growth through the suppression of mTOR pathwayIdentification of protein interactions involved in cellular signalingThe broken "Off" switch in cancer signaling: PP2A as a regulator of tumorigenesis, drug resistance, and immune surveillanceC-Jun N-terminal kinase signalling pathway in response to cisplatinProtein Phosphatase 2A as a Therapeutic Target in Acute Myeloid LeukemiaLB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potentialRegulation of PP2A by Sphingolipid Metabolism and SignalingPPP2R5C Couples Hepatic Glucose and Lipid HomeostasisCIP2A Promotes T-Cell Activation and Immune Response to Listeria monocytogenes InfectionReconstruction of mouse testicular cellular microenvironments in long-term seminiferous tubule cultureCIP2A down regulation enhances the sensitivity of pancreatic cancer cells to gemcitabine.PhosphoTyrosyl phosphatase activator of Plasmodium falciparum: identification of its residues involved in binding to and activation of PP2AThe Basic Biology of PP2A in Hematologic Cells and MalignanciesPP2A: The Wolf in Sheep's Clothing?Immediate-early response 5 (IER5) interacts with protein phosphatase 2A and regulates the phosphorylation of ribosomal protein S6 kinase and heat shock factor 1Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cellsComputer-aided targeting of the PI3K/Akt/mTOR pathway: toxicity reduction and therapeutic opportunitiesOverexpression and small molecule-triggered downregulation of CIP2A in lung cancermRNA expression analysis of cell cycle genes in islets of pregnant miceProtein Phosphatase Methyl-Esterase PME-1 Protects Protein Phosphatase 2A from Ubiquitin/Proteasome DegradationCIP2A promotes proliferation of spermatogonial progenitor cells and spermatogenesis in miceFTY720 inhibits mesothelioma growth in vitro and in a syngeneic mouse modelActivation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth.Relevance Rank Platform (RRP) for Functional Filtering of High Content Protein-Protein Interaction Data.Protein Ser/Thr phosphatases--the ugly ducklings of cell signalling.Regulation of c-Myc Protein Abundance by a Protein Phosphatase 2A-Glycogen Synthase Kinase 3β-Negative Feedback Pathway.Shank-interacting protein-like 1 promotes tumorigenesis via PTEN inhibition in human tumor cells.Fusogenic-oligoarginine peptide-mediated delivery of siRNAs targeting the CIP2A oncogene into oral cancer cells.Synergy between proteasome inhibitors and imatinib mesylate in chronic myeloid leukemia.Preferential autoimmune response in prostate cancer to cyclin B1 in a panel of tumor-associated antigensmiR-375 activates p21 and suppresses telomerase activity by coordinately regulating HPV E6/E7, E6AP, CIP2A, and 14-3-3ζRapid estrogen receptor signaling mediates estrogen-induced inhibition of vascular smooth muscle cell proliferation.Ethoxysanguinarine Induces Inhibitory Effects and Downregulates CIP2A in Lung Cancer Cells.Overexpression of CIP2A is an independent prognostic indicator in nasopharyngeal carcinoma and its depletion suppresses cell proliferation and tumor growth.Tumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinoma
P2860
Q21198842-873AC410-54DD-4127-A02C-DEA7C9AF6A08Q24300312-6AC580DC-6981-4C47-ACD4-B01CF3A79D84Q24302544-683DAF9E-5B37-42B6-87C3-32FE961C83E7Q24308344-77158CCF-B15D-4389-84DB-7E8589DC5F2AQ24322118-8C419527-54D7-4E45-AF99-8A04886DC4DBQ24338396-36FF3942-02A3-482E-92CF-3ED410B83C82Q24601574-91A68386-1C6A-487B-96AF-FAA602EAF45CQ26739246-4728BD3A-5C0B-4224-A34B-94D61CAE2296Q26745463-A05F7835-9B46-4F7A-A653-7AA4547F6113Q26752430-381A6E86-61C4-4838-A368-832C929BF1CBQ26865711-8CED48E7-F1A4-4462-AAD7-5515D19216A2Q27026038-8C4265B5-6991-4717-AACC-1863338961DCQ27310235-FE7C3047-EF57-4151-B803-292FC014504BQ27314902-4751B32C-153D-432E-81AB-1A22C4820D12Q27319183-492BEB0A-4618-404D-979B-B73FA5628C92Q27853345-85BA0AF1-012F-4618-B904-ACEDA3405ACBQ27974345-10D32E49-0E2F-4A53-9AF0-80140E8DE8E8Q28088697-7C0ABA35-F472-4CE0-AE60-70802ACC6A73Q28088747-40D92EE2-7545-41E8-AD64-5D753BCFD836Q28118123-7050C76B-B92D-4B4E-9503-294FE0CCC93CQ28299365-6ADB6219-0E99-485D-BB73-5EF980F211F2Q28397537-C1D50ABA-2910-4580-8F66-9279755C5B9AQ28478368-3D6D7CD5-F091-4AED-B23C-A11154EC27F4Q28508233-DAF38BCE-BF9E-42B1-B7B2-33F7D45C4DB6Q28551570-5064B00F-0354-4DCB-B6EC-6B044C1ABFAFQ28590389-A34F3129-8F83-4A54-940C-1D0E78C58980Q29248124-579FE2D2-D968-4B37-B00F-4EB39B1452B4Q30252408-BC30D1BF-2D08-4692-8EFB-2861981C79BAQ30368859-7A71C645-5703-4AC2-8F57-229623728D1CQ30455386-2536F27B-CAF4-4EE9-8244-992BFE34287DQ30464719-56006928-BA6C-4ACA-A898-DBED2ECCA491Q30494717-BA451CED-CD27-423E-BE09-14C6FEF8818CQ31137535-4A7EEEE9-8DA8-4DFE-AE45-A9C6D8D73061Q33482818-386B7E8B-BAD5-4BBC-A37E-1AE7469EED21Q33594076-3EAEE0CE-E3BB-43B9-A82C-DB52CE043896Q33614271-88717820-067F-42E8-AD8D-50EBEFF8B0D5Q33621370-78EF6BEB-B28C-448B-8D68-6D4BB8C85D54Q33636463-9AEDEB62-8B44-43CF-80A8-BBC7D848ECB2Q33712856-DBA449E8-D8D0-4E13-8402-5BA50E857D91Q33719973-810E719F-7617-4909-BAD0-582032913B34
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
CIP2A inhibits PP2A in human malignancies
@ast
CIP2A inhibits PP2A in human malignancies
@en
CIP2A inhibits PP2A in human malignancies
@en-gb
CIP2A inhibits PP2A in human malignancies
@nl
type
label
CIP2A inhibits PP2A in human malignancies
@ast
CIP2A inhibits PP2A in human malignancies
@en
CIP2A inhibits PP2A in human malignancies
@en-gb
CIP2A inhibits PP2A in human malignancies
@nl
prefLabel
CIP2A inhibits PP2A in human malignancies
@ast
CIP2A inhibits PP2A in human malignancies
@en
CIP2A inhibits PP2A in human malignancies
@en-gb
CIP2A inhibits PP2A in human malignancies
@nl
P2093
P3181
P1433
P1476
CIP2A inhibits PP2A in human malignancies
@en
P2093
Christina Nielsen
Edward K L Chan
Hugh Arnold
Juergen Kast
Melissa R Junttila
Minna Niemelä
Pietri Puustinen
Raija Ahola
Reidar Grènman
Risto Ala-aho
P3181
P356
10.1016/J.CELL.2007.04.044
P407
P577
2007-07-13T00:00:00Z